
The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide — the active agent in Ozempic and Wegovy — had as much as a 52% reduction in kidney damage, as measured by urine testing, researchers reported Oct. 25 in the journal Nature Medicine. The results will… read on > read on >